Sally Yellson

Doctor of Medicine,  CharitĂ© - Universitätsmedizin Berlin 

Location: United States

Consulting Services

Scientific Writing Admin and Customer Support Legal Support

Areas Of Interest

Indometacin Lipidoses, Sphingomyelin Echogenic Bowels Receptors, C Type Lectin Parakeet, Rose-ringed Viral Encephalitis RAR alpha 2 Delusory Parasitosis Cetirizine Dihydrochloride Anti-gamma Globulin Antibodies Counter, Whole-Body Chorismate Mutase Prephenate Dehydrogenase Acellular Dermi Cefotaxim CD88 Antigens Canine Adenoviruses Tournefortia OAT Transport Proteins Computer Neural Network SC-13957 Factor 12 Deficiencies Behaviors, Cooperative Acalypha Trocars Skin Bleaching Agent NADPH-Dependent 20 alpha-Hydroxysteroid Oxidoreductase Raphes Obscurus, Nucleus Waist Hip Ratio Antineoplastic Agents Insemination TCF 1 Transcription Factor Serums, Immune Theory, Jungian

Professional Narrative

Dr. Sally Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Mayo Clinic 2011
Senior Director, Harvard Med 2012

Education

Doctor of medicine, Weill Medical College 1987
Doctor of medicine, Yale School of Medicine 2014

Referees


Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :